Claritev Corp CTEV
Claritev Corporation is a technology, data and insights company focused on improving transparency, affordability and quality across the healthcare system. Claritev brings objective, market-based insights to some of the healthcare system's most complex decisions - grounded in decades of claims experience. By applying data, analytics and experience, Claritev helps organizations across the healthcare ecosystem better understand costs, pricing and payment dynamics. This clarity enables more informed decision-making, reduces friction and improves how the healthcare system functions in service of greater affordability, alignment and long-term sustainability. Founded in 1980, Claritev brings over 45 years of claims and data experience and builds on world-class technology and artificial intelligence ("AI") solutions, to deliver its portfolio of product and service offerings.
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $965.4M | $930.6M | $961.5M | $1.08B | $1.12B | $937.8M | $982.9M | $1.04B | — |
| SG&A | $221.5M | $150.9M | $143.2M | $166.8M | $151.1M | $355.6M | $75.2M | $77.6M | — |
| Total operating expenses | $936.6M | $2.32B | $799.5M | $1.44B | $731.5M | $1.07B | $614.7M | $613.3M | — |
| Operating income | $28.8M | -$1.39B | $162.0M | -$362.7M | $386.1M | -$131.8M | $368.2M | $427.5M | — |
| Interest expense | $392.0M | $326.4M | $333.2M | $303.4M | $267.5M | $335.6M | $376.3M | $383.3M | — |
| Pre-tax income | -$373.1M | -$1.77B | -$107.1M | -$560.7M | $135.5M | $135.5M | -$546.9M | $10.5M | — |
| Income tax | $88.8M | $124.9M | $15.4M | $12.2M | $33.4M | $33.4M | $26.3M | $800.0K | — |
| Net income | -$284.3M | -$1.65B | -$91.7M | -$572.9M | $102.1M | -$520.6M | $9.7M | $36.2M | — |
| EPS, basic | -17.30 | -101.92 | -5.69 | -0.90 | 0.16 | -1.11 | 0.02 | — | — |
| EPS, diluted | -17.30 | -101.92 | -5.69 | -0.90 | 0.16 | -1.11 | 0.02 | 0.09 | — |
| Shares, diluted (wtd. avg.) | 16.4M | 16.1M | 16.1M | 638.9M | 651.5M | 470.8M | 415.7M | — | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $16.8M | $16.8M | $71.5M | $340.6M | $185.3M | $126.8M | $21.8M | $5.0M | $21.4M |
| Receivables | $127.6M | $89.8M | $76.6M | $78.9M | $99.9M | $63.2M | $77.1M | — | — |
| Total current assets | $224.4M | $175.5M | $193.6M | $446.7M | $319.3M | $208.9M | $115.6M | — | — |
| Goodwill | $2.41B | $2.40B | $3.83B | $3.71B | $4.36B | $4.26B | $4.14B | $4.14B | — |
| Other intangibles | $1.88B | $2.23B | $2.63B | $2.94B | $3.29B | $3.58B | $3.89B | — | — |
| Total assets | $4.89B | $5.15B | $6.96B | $7.37B | $8.22B | $8.28B | $8.36B | — | — |
| Accounts payable | $60.5M | $86.3M | $19.6M | $13.3M | $13.0M | $15.3M | $9.6M | — | — |
| Short-term debt | $14.7M | $13.2M | $13.2M | $13.2M | $13.2M | $0 | — | — | — |
| Total current liabilities | $261.4M | $213.8M | $166.7M | $175.8M | $141.9M | $112.5M | $85.8M | — | — |
| Long-term debt | $4.61B | $4.57B | $4.60B | $4.82B | $4.97B | — | — | — | — |
| Total liabilities | $5.06B | $5.07B | $5.26B | $5.58B | $5.88B | $5.73B | $6.38B | — | — |
| Retained earnings | -$2.43B | -$2.15B | -$499.3M | -$347.8M | $225.1M | $117.0M | $637.6M | — | — |
| Total equity | -$173.9M | $84.0M | $1.71B | $1.79B | $2.34B | $2.56B | $1.99B | $1.99B | $1.95B |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $117.3M | $107.6M | $171.7M | $372.4M | $404.7M | $377.4M | $284.3M | $292.3M | — |
| Depreciation and amortisation | $101.7M | $88.2M | $77.3M | $68.8M | $64.9M | $60.6M | $55.8M | $52.3M | — |
| Stock-based compensation | $27.8M | $26.6M | $18.0M | $16.7M | $18.0M | $406.1M | -$14.9M | $4.7M | — |
| Capital expenditure | $129.6M | $118.1M | $108.9M | $89.7M | $84.6M | $70.8M | $66.4M | $63.6M | — |
| Investing cash flow | -$121.0M | -$118.1M | -$249.8M | -$104.4M | -$228.4M | -$210.8M | -$66.4M | -$63.6M | — |
| Financing cash flow | $2.4M | -$41.3M | -$181.0M | -$115.7M | -$114.7M | -$61.6M | -$201.1M | -$245.2M | — |
| Buybacks | $0 | $10.4M | $15.2M | $0 | $100.0M | $101.1M | $0 | $0 | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001793229-26-000017.
Plot the figures US dollars
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $1.04B | $982.9M | $937.8M | $1.12B | $1.08B | $961.5M | $930.6M | $965.4M |
| Gross profit | — | — | — | — | — | — | — | — | — |
| Net income | — | $36.2M | $9.7M | -$520.6M | $102.1M | -$572.9M | -$91.7M | -$1.65B | -$284.3M |
Recent filings and events
- Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
- Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
- Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
- Regulation FD disclosure Item 7.01
- Results announced Item 2.02
- Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
- Shareholder vote The results of the annual meeting or a special vote. Item 5.07
- Regulation FD disclosure Item 7.01
- Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
- Results announced Item 2.02
- Regulation FD disclosure Item 7.01
- Officer or director change Item 5.02
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 7389
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| MA | Mastercard Inc | $550.02B | 37.7x | 16.4% |
| ACN | Accenture plc | $152.67B | 20.5x | 7.4% |
| UBER | Uber Technologies, Inc | $136.24B | 14.1x | 18.3% |
| MELI | MERCADOLIBRE INC | $91.77B | 45.9x | 34.3% |
| DASH | DoorDash, Inc. | $77.93B | 84.2x | 27.9% |
| EBAY | EBAY INC | $54.03B | 28.0x | 7.9% |
| PYPL | PayPal Holdings, Inc. | $50.30B | 10.5x | 4.3% |
| MSCI | MSCI Inc. | $44.76B | 39.2x | 9.7% |